跳至主要内容
临床试验/NCT06514079
NCT06514079招募中不适用

Role of Topical Steroid Injection With Refractory Benign Esophageal Stricture Endoscopic Dilatation in Children

Mohammad Daboos2 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2022年3月2日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
21
试验地点
2
主要终点
Maximum dilatation size

研究概览

简要总结

This clinical trial study included 21 children with refractory benign esophageal strictures. Upper GI endoscopy performed up to the area of stricture, esophageal dilatation done, endoscopy repeated, and steroid injected intralesional under direct endoscopic vision. The effect of the procedure was followed over a period of 12 months by evaluation of number of dilatation, maximum dilator size, periodic dilatation index (PDI) and dysphagia score.

详细描述

Background and study aims: Benign esophageal strictures are primarily treated with dilation therapy, but strictures can recur or can be unresponsive, requiring additional or repeated treatment. This study investigates the efficacy and safety of intralesional steroid injections (ISIs) in addition to dilation in patients with refractory benign esophageal strictures.

Methods: This clinical trial study included 21 children with refractory benign esophageal strictures. Upper GI endoscopy performed up to the area of stricture, esophageal dilatation done, endoscopy repeated, and steroid injected intralesional under direct endoscopic vision. The effect of the procedure was followed over a period of 12 months by evaluation of number of dilatation, maximum dilator size, periodic dilatation index (PDI) and dysphagia score.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
2 Years 至 14 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Pediatric patients aged less than 14 years
  • with refractory benign esophageal strictures
  • received a dilatation therapy without triamcinolone injections

排除标准

  • failure to pass a guide wire secondary to pharyngeal stenosis
  • tracheo-esophageal fistula
  • those who received triamcinolone injections at early dilatation

结局指标

主要结局

Maximum dilatation size

时间窗: 12 months

achieving a diameter of 11 mm for patients aged \<2 years, 12 mm for patients aged between 2 and 5 years, and 15 mm for children aged \>5 years with complete relief of symptoms without requiring endoscopic procedure or surgical intervention for at least 6 months

次要结局

  • dysphagia score(12 months)

研究者

发起方
Mohammad Daboos
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Mohammad Daboos

Professor at Pediatric Surgery Department, Al-Azhar University.

Al-Azhar University

研究点 (2)

Loading locations...

相似试验